Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand

Part of paid clinical trials in Buffalo, New York.

Sponsor
Roswell Park Cancer Institute
Study ID
NCT07102082
Status
Recruiting
Apply to this trial

Conditions

  • Smoking Behaviors

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Modified Risk - None — BEHAVIORAL
    Participants view ads with no modified risk claim
  • Modified Risk Claim — BEHAVIORAL
    Participants view ads with a modified risk claim

Study Details

To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.

Key Dates

Start date
Sep 25, 2025
Status verified
May 2026
Primary completion
Sep 30, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
160 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Sham Comparator: Group A - no claim
    Participants view smokeless tobacco ads with no claims
  • Active Comparator: Group B - Modified Risk Tobacco Product Claim
    Participants view ads with a modified risk claim

Primary Outcome Measure

Demand for cigarettes [ Time Frame: After one session - 1 hour ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Roswell ParkBuffaloNew York14206-

Find similar trials in Buffalo, NY

By research site
Roswell Park· Buffalo, NY

Related Studies